Health

Our PhD candidates have a laser-sharp focus on industry and translating lab ideas into real-life outcomes. Here are two AIBN scholars who teamed up with industry partners for their research, then landed a job with them.

Sonodynamic therapy is a promising, non-invasive cancer treatment. And now AIBN researchers think they've made the process even more effective.

At the AIBN, our researchers are pushing the boundaries of personalised medicine: developing new, patient-specific treatments to address serious diseases. But we’ve also got people whose mission is to prevent sickness in the first place.

In the hunt for new and more sophisticated cancer-fighting tools, theranostics are a promising double-act: an emerging group of materials capable of identifying and healing tumours.

Yeast has long been a cheap and abundant ingredient in bread and beer and thanks to its unique chemical properties, it can now be used in diagnostic technologies that rival PCR testing for speed and sensitivity.

Could specific sensor techniques help us dodge a looming zoonotic COVID-19 threat? AIBN researchers are gathering evidence that suggests so.

AIBN researchers have won $500,000 to design an easy-to-use device that can effectively apply their groundbreaking snake venom hydrogel.

A thin, flexible gold sensor engineered at the AIBN has the potential to unlock the next generation of implantable medical devices.

Tiny brains grown in a lab could help The University of Queensland (UQ) researchers find a treatment for a rare hereditary disease and, in the process, unlock therapies for a range of other neurological disorders.

A University of Queensland (UQ) spin out company will use the traditional Indigenous knowledge of spinifex from the Queensland outback to develop innovative medical gels.